INVESTOR CONTACT: | ||||
Jennifer Gianola | ||||
+1 (408) 831-4452 | ||||
jennifer.gianola@gigamon.com | ||||
• | Revenue of $79.2 million, compared to $83.5 million in the third quarter of fiscal 2016. |
• | GAAP gross margin was 82%, compared to 83% in the third quarter of fiscal 2016. |
• | Non-GAAP gross margin was 82%, compared to 83% in the third quarter of fiscal 2016. |
• | GAAP net income was $2.2 million, or $0.06 per basic and diluted share, compared to GAAP net income of $6.1 million, or $0.16 per diluted share, in the third quarter of fiscal 2016. |
• | Non-GAAP net income was $9.5 million or $0.23 per diluted share, compared to non-GAAP net income of $14.0 million, or $0.36 per diluted share, in the third quarter of fiscal 2016. |
• | Cash and short-term investments were $264.6 million, up $6 million from the second quarter of 2017 and up $20 million from the third quarter of fiscal 2016. |
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, 2017 | October 1, 2016 | September 30, 2017 | October 1, 2016 | ||||||||||||
Revenue: | |||||||||||||||
Product | $ | 51,861 | $ | 59,835 | $ | 139,063 | $ | 155,805 | |||||||
Service | 27,330 | 23,677 | 78,832 | 70,021 | |||||||||||
Total revenue | 79,191 | 83,512 | 217,895 | 225,826 | |||||||||||
Cost of revenue: | |||||||||||||||
Product | 11,401 | 12,197 | 32,429 | 34,414 | |||||||||||
Service | 3,049 | 2,141 | 8,649 | 6,562 | |||||||||||
Total cost of revenue | 14,450 | 14,338 | 41,078 | 40,976 | |||||||||||
Gross profit | 64,741 | 69,174 | 176,817 | 184,850 | |||||||||||
Operating expenses: | |||||||||||||||
Research and development | 18,783 | 18,306 | 59,451 | 50,914 | |||||||||||
Sales and marketing | 34,914 | 31,994 | 105,247 | 88,494 | |||||||||||
General and administrative | 10,697 | 8,887 | 30,033 | 26,029 | |||||||||||
Total operating expenses | 64,394 | 59,187 | 194,731 | 165,437 | |||||||||||
Income (loss) from operations | 347 | 9,987 | (17,914 | ) | 19,413 | ||||||||||
Other income (expense): | |||||||||||||||
Interest income | 541 | 235 | 1,374 | 661 | |||||||||||
Other expense, net | (241 | ) | (144 | ) | (433 | ) | (386 | ) | |||||||
Income (loss) before income tax (provision) benefit | 647 | 10,078 | (16,973 | ) | 19,688 | ||||||||||
Income tax benefit (provision) | 1,531 | (3,999 | ) | 9,576 | 23,321 | ||||||||||
Net income (loss) | $ | 2,178 | $ | 6,079 | $ | (7,397 | ) | $ | 43,009 | ||||||
Net income (loss) per share: | |||||||||||||||
Basic | $ | 0.06 | $ | 0.17 | $ | (0.20 | ) | $ | 1.22 | ||||||
Diluted | $ | 0.06 | $ | 0.16 | $ | (0.20 | ) | $ | 1.15 | ||||||
Weighted average shares used in computing net income (loss) per share: | |||||||||||||||
Basic | 37,196 | 35,770 | 36,885 | 35,171 | |||||||||||
Diluted | 39,574 | 38,113 | 36,885 | 37,341 | |||||||||||
September 30, 2017 | December 31, 2016 | ||||||
ASSETS | |||||||
CURRENT ASSETS: | |||||||
Cash and cash equivalents | $ | 173,182 | $ | 148,926 | |||
Short-term investments | 91,380 | 109,238 | |||||
Accounts receivable, net | 71,741 | 75,522 | |||||
Inventories, net | 15,472 | 11,347 | |||||
Prepaid expenses and other current assets | 12,048 | 9,909 | |||||
Total current assets | 363,823 | 354,942 | |||||
Property and equipment, net | 20,735 | 11,809 | |||||
Deferred tax assets, non-current | 50,734 | 33,094 | |||||
Other assets, non-current | 1,103 | 1,154 | |||||
TOTAL ASSETS | $ | 436,395 | $ | 400,999 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
CURRENT LIABILITIES: | |||||||
Accounts payable | $ | 5,585 | $ | 5,208 | |||
Accrued liabilities | 26,897 | 34,649 | |||||
Deferred revenue | 69,960 | 68,997 | |||||
Total current liabilities | 102,442 | 108,854 | |||||
Deferred revenue, non-current | 32,126 | 28,785 | |||||
Deferred and other tax liabilities, non-current | 553 | 201 | |||||
Other liabilities, non-current | 933 | 499 | |||||
TOTAL LIABILITIES | 136,054 | 138,339 | |||||
STOCKHOLDERS' EQUITY | |||||||
Common stock | 4 | 4 | |||||
Additional paid-in-capital | 298,400 | 256,774 | |||||
Accumulated other comprehensive loss | (75 | ) | (17 | ) | |||
Retained earnings (Accumulated deficit) | 2,012 | 5,899 | |||||
TOTAL STOCKHOLDERS' EQUITY | 300,341 | 262,660 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 436,395 | $ | 400,999 | |||
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, 2017 | October 1, 2016 | September 30, 2017 | October 1, 2016 | ||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||
Net income (loss) | $ | 2,178 | $ | 6,079 | $ | (7,397 | ) | $ | 43,009 | ||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||||||||
Depreciation and amortization | 2,214 | 1,642 | 6,411 | 4,815 | |||||||||||
Stock-based compensation expense | 10,973 | 10,104 | 39,991 | 28,884 | |||||||||||
Deferred and other income taxes | (1,790 | ) | (679 | ) | (10,147 | ) | (31,570 | ) | |||||||
Other | 6 | 54 | 148 | 366 | |||||||||||
Changes in operating assets and liabilities: | |||||||||||||||
Accounts receivable | (8,221 | ) | (14,929 | ) | 3,672 | (11,567 | ) | ||||||||
Inventories | (1,336 | ) | (862 | ) | (4,761 | ) | (4,316 | ) | |||||||
Prepaid expenses and other assets | 78 | (1,753 | ) | (1,944 | ) | (2,991 | ) | ||||||||
Accounts payable | 1,757 | 569 | 532 | 54 | |||||||||||
Accrued liabilities and other liabilities | 1,083 | 9,227 | (9,308 | ) | 3,470 | ||||||||||
Deferred revenue | 5,413 | 3,290 | 4,304 | 1,015 | |||||||||||
Net cash provided by (used in) operating activities | 12,355 | 12,742 | 21,501 | 31,169 | |||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||
Purchase of short-term investments | (8,941 | ) | (20,942 | ) | (78,099 | ) | (84,773 | ) | |||||||
Proceeds from maturities of short-term investments | 25,300 | 24,500 | 96,012 | 85,747 | |||||||||||
Purchase of property and equipment | (6,977 | ) | (1,523 | ) | (12,179 | ) | (6,001 | ) | |||||||
Net cash provided by (used in) investing activities | 9,382 | 2,035 | 5,734 | (5,027 | ) | ||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||
Proceeds from employee stock purchase plan | 4,487 | 3,417 | 9,443 | 6,785 | |||||||||||
Proceeds from exercise of stock options | 40 | 5,528 | 983 | 9,654 | |||||||||||
Shares repurchased for tax withholdings on vesting of restricted stock units | (4,188 | ) | (3,411 | ) | (12,592 | ) | (7,240 | ) | |||||||
Net cash provided by (used in) financing activities | 339 | 5,534 | (2,166 | ) | 9,199 | ||||||||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 22,076 | 20,311 | 25,069 | 35,341 | |||||||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period | 151,919 | 135,242 | 148,926 | 120,212 | |||||||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — End of period | $ | 173,995 | $ | 155,553 | $ | 173,995 | $ | 155,553 | |||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, 2017 | October 1, 2016 | September 30, 2017 | October 1, 2016 | ||||||||||||
Total Revenue | $ | 79,191 | $ | 83,512 | $ | 217,895 | $ | 225,826 | |||||||
Reconciliation of GAAP Gross Profit and GAAP Gross Margin to Non-GAAP Gross Profit and Non-GAAP Gross Margin: | |||||||||||||||
GAAP gross profit | 64,741 | 69,174 | 176,817 | 184,850 | |||||||||||
Stock-based compensation expense | 333 | 519 | 1,802 | 1,527 | |||||||||||
Stock-based compensation related payroll taxes | 19 | 28 | 79 | 64 | |||||||||||
Non-GAAP gross profit | $ | 65,093 | $ | 69,721 | $ | 178,698 | $ | 186,441 | |||||||
GAAP gross margin | 82 | % | 83 | % | 81 | % | 82 | % | |||||||
Non-GAAP gross margin | 82 | % | 83 | % | 82 | % | 83 | % | |||||||
Reconciliation of GAAP Operating Income (Loss) to Non-GAAP Operating Income: | |||||||||||||||
GAAP operating income (loss) | $ | 347 | $ | 9,987 | $ | (17,914 | ) | $ | 19,413 | ||||||
Stock-based compensation expense | 10,973 | 10,104 | 39,991 | 28,884 | |||||||||||
Stock-based compensation related payroll taxes | 199 | 414 | 1,036 | 971 | |||||||||||
Non-recurring items | 2,305 | — | 2,891 | — | |||||||||||
Non-GAAP operating income | $ | 13,824 | $ | 20,505 | $ | 26,004 | $ | 49,268 | |||||||
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income: | |||||||||||||||
GAAP net income (loss) | $ | 2,178 | $ | 6,079 | $ | (7,397 | ) | $ | 43,009 | ||||||
Stock-based compensation expense | 10,973 | 10,104 | 39,991 | 28,884 | |||||||||||
Stock-based compensation related payroll taxes | 199 | 414 | 1,036 | 971 | |||||||||||
Non-recurring items | 2,305 | — | 2,891 | — | |||||||||||
Income tax effect of Non-GAAP adjustments | (6,189 | ) | (2,593 | ) | (18,468 | ) | (39,176 | ) | |||||||
Non-GAAP net income | $ | 9,466 | $ | 14,004 | $ | 18,053 | $ | 33,688 | |||||||
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, 2017 | October 1, 2016 | September 30, 2017 | October 1, 2016 | ||||||||||||
Reconciliation of GAAP Diluted Net Income (Loss) per Share to Non-GAAP Diluted Net Income per Share: | |||||||||||||||
GAAP diluted net income (loss) per share | $ | 0.06 | $ | 0.16 | $ | (0.20 | ) | $ | 1.15 | ||||||
Stock-based compensation expense | 0.27 | 0.27 | 1.08 | 0.77 | |||||||||||
Stock-based compensation related payroll taxes | 0.01 | 0.01 | 0.03 | 0.03 | |||||||||||
Non-recurring items | 0.06 | — | 0.08 | — | |||||||||||
Income tax effect of non-GAAP adjustments | (0.16 | ) | (0.07 | ) | (0.50 | ) | (1.05 | ) | |||||||
Impact of difference in number of GAAP and non-GAAP diluted shares | (0.01 | ) | (0.01 | ) | (0.05 | ) | (0.01 | ) | |||||||
Non-GAAP diluted net income per share | $ | 0.23 | $ | 0.36 | $ | 0.44 | $ | 0.89 | |||||||
Reconciliation of GAAP Diluted Weighted-Average Number of Shares to Non-GAAP Diluted Weighted-Average Number of Shares: | |||||||||||||||
GAAP diluted weighted-average number of shares | 39,574 | 38,113 | 36,885 | 37,341 | |||||||||||
Dilutive impact due to stock-based compensation | 1,546 | 544 | 3,827 | 673 | |||||||||||
Non-GAAP diluted weighted-average number of shares | 41,120 | 38,657 | 40,712 | 38,014 | |||||||||||